Ferritin: Which Tests to Order Alongside for a Complete Picture

What Ferritin Actually Measures

Ferritin is an intracellular protein that stores iron in a soluble, non-toxic form and releases it in a controlled fashion. The small amount that circulates in blood reflects total body iron reserves. A 2021 review in Blood confirmed that each 1 ng/mL of serum ferritin corresponds to roughly 8 mg of stored iron under non-inflammatory conditions [1].

The problem is that ferritin doubles as an acute-phase reactant. Infection, autoimmune flares, liver disease, obesity, and even heavy alcohol intake can push ferritin up by 2- to 10-fold without any change in iron status [2]. This is why ordering ferritin in isolation creates blind spots. A patient with rheumatoid arthritis and true iron deficiency may show a ferritin of 80 ng/mL, well within "normal" range, while their tissue iron stores are depleted. The World Health Organization revised its iron-deficiency threshold in 2020 to account for this, recommending a cutoff of <70 ng/mL (rather than <15 ng/mL) when concurrent inflammation is present [3].

The inverse problem also exists. A mildly elevated ferritin of 350 ng/mL might represent early hereditary hemochromatosis, metabolic syndrome with hepatic steatosis, or simply a recent viral illness. No single number tells you which scenario you are in. You need paired tests.

The Core Panel: Serum Iron, TIBC, and Transferrin Saturation

Every ferritin order should include a serum iron panel. This trio of tests, serum iron, total iron-binding capacity (TIBC), and transferrin saturation (TSAT), provides the kinetic complement to ferritin's static storage snapshot.

Serum iron fluctuates throughout the day and after meals, so it is unreliable on its own. TIBC measures how much transferrin is available to bind iron; it rises when iron stores are low and falls when they are high. TSAT, calculated as serum iron divided by TIBC and multiplied by 100, is the most clinically actionable number in the panel. The American Association for the Study of Liver Diseases (AASLD) recommends using a fasting TSAT above 45% as the initial screening threshold for hereditary hemochromatosis [4].

When ferritin is low and TSAT is below 20%, the diagnosis of iron deficiency is straightforward. When ferritin is elevated and TSAT exceeds 45%, iron overload warrants investigation with HFE gene testing. The gray zone, a ferritin between 200 and 500 ng/mL with a TSAT between 20% and 45%, is where adding CRP and liver enzymes becomes essential to separate metabolic causes from true iron loading [5].

A 2022 cohort analysis published in the American Journal of Hematology (N=4,812 primary-care patients) found that ordering ferritin without TSAT led to misclassification of iron status in 23% of cases, a rate that dropped to 4% when the full panel was used [6].

CBC with Differential: The Anemia Check

A complete blood count with differential is the second non-negotiable companion to ferritin. Hemoglobin, hematocrit, mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), and red cell distribution width (RDW) together reveal whether iron deficiency has progressed to overt anemia and help distinguish it from other causes of low hemoglobin.

Iron-deficiency anemia classically presents as microcytic (MCV <80 fL) and hypochromic (MCH <27 pg) with an elevated RDW above 14.5%. But early iron depletion can exist with a normal MCV for weeks before the red cells shrink. In the NHANES III dataset (N=15,801), 37% of adults with ferritin <15 ng/mL had a normal MCV, meaning their iron deficiency would have been invisible on a CBC alone [7].

The differential adds another layer. Eosinophilia may suggest parasitic iron loss. An elevated monocyte count could indicate chronic inflammation driving the ferritin. Thrombocytosis, reactive platelet elevation, is a common but underrecognized marker of iron deficiency, especially in premenopausal women [8].

CRP or ESR: Separating Iron from Inflammation

Because ferritin rises as part of the inflammatory response, pairing it with C-reactive protein (CRP) or erythrocyte sedimentation rate (ESR) is the minimum step needed to determine whether an elevated ferritin is meaningful for iron status.

The mechanism is straightforward. Interleukin-6 upregulates hepcidin, which traps iron inside macrophages and hepatocytes, raising ferritin while paradoxically limiting iron availability for red cell production. This is the hallmark of anemia of chronic disease (ACD), also called anemia of inflammation. A 2019 Cochrane review concluded that CRP should be measured alongside ferritin in any population with a high prevalence of infection or chronic disease to avoid overestimating iron stores [9].

A practical heuristic used in hematology practice: if CRP is above 5 mg/L, multiply the ferritin threshold for iron deficiency by 3. So instead of using <30 ng/mL, consider ferritin <100 ng/mL as suspicious for iron deficiency. The WHO's 2020 guideline formalized a similar approach, recommending a ferritin cutoff of <70 ng/mL when CRP exceeds 5 mg/L [3].

High-sensitivity CRP (hs-CRP) is preferred over standard CRP when the clinical question is specifically about low-grade chronic inflammation (obesity, metabolic syndrome, cardiovascular risk) rather than acute infection.

Soluble Transferrin Receptor: The Underused Differentiator

Soluble transferrin receptor (sTfR) deserves a place in the paired-test discussion even though it is ordered far less often than CRP or a CBC. sTfR rises when cells are iron-starved, regardless of inflammation. This makes it the single best test for detecting tissue iron deficiency in patients with concurrent chronic disease.

The HealthRX Iron Diagnostic Decision Framework:

1. Ferritin low + CRP normal + TSAT <20% = straightforward iron deficiency. Proceed to cause-finding (GI evaluation, menstrual history, dietary assessment).
2. Ferritin normal/high + CRP elevated + TSAT <20% = suspected anemia of chronic disease with possible concurrent iron deficiency. Order sTfR. An sTfR/log-ferritin index above 2.0 confirms coexisting iron deficiency [10].
3. Ferritin high + CRP normal + TSAT >45% = iron overload pattern. Order HFE genotyping and fasting repeat TSAT.
4. Ferritin 300 to 1,000 ng/mL + CRP normal + TSAT 20 to 45% = metabolic hyperferritinemia likely. Order ALT, AST, GGT, fasting glucose, HbA1c, and hepatic ultrasound.
5. Ferritin >1,000 ng/mL, any scenario = urgent workup. Consider hepatology referral, MRI-based liver iron concentration, and evaluation for hemophagocytic lymphohistiocytosis (HLH) or malignancy.

The sTfR/log-ferritin ratio (also called the Thomas plot or ferritin index) was validated in a 2003 study by Thomas and Thomas (N=1,100) and has since been incorporated into multiple European guidelines for differentiating ACD from ACD with concurrent iron deficiency [10]. It remains underutilized in U.S. primary care, in part because sTfR is not included in standard iron panels and must be ordered separately.

Reticulocyte Count and Reticulocyte Hemoglobin

When anemia is already established (hemoglobin <12 g/dL in women, <13 g/dL in men by WHO criteria), a reticulocyte count with reticulocyte hemoglobin content (CHr or Ret-He) adds real-time information about the bone marrow's iron supply.

Reticulocyte hemoglobin reflects iron availability to developing red cells over the preceding 48 to 72 hours, far more current than ferritin's weeks-long lag time. A CHr below 28 pg identifies iron-restricted erythropoiesis with high sensitivity [11]. The 2018 Kidney Disease: Improving Global Outcomes (KDIGO) anemia guideline specifically recommends CHr or percentage of hypochromic red cells (%HRC >6%) as functional iron markers in patients with chronic kidney disease (CKD), where ferritin is chronically elevated by the disease state itself [12].

This test is particularly valuable for patients on erythropoiesis-stimulating agents (ESAs) or those being evaluated for IV iron therapy. A CHr below 28 pg predicts response to IV iron with a positive predictive value of 86% [11].

Liver Function Tests: When Ferritin Goes High

Hepatocytes are the largest ferritin reservoir in the body. Liver damage, whether from alcohol, non-alcoholic fatty liver disease (NAFLD), viral hepatitis, or iron overload itself, causes ferritin to leak into the bloodstream independent of total body iron. A 2014 analysis in Hepatology (N=12,090 from NHANES III) found that ALT elevation was the strongest independent predictor of hyperferritinemia, surpassing both BMI and CRP [13].

When ferritin exceeds 500 ng/mL, ordering a hepatic panel (ALT, AST, GGT, alkaline phosphatase, albumin, bilirubin) is standard practice. GGT is especially useful because it rises early in both alcohol-related liver injury and metabolic dysfunction-associated steatotic liver disease (MASLD, formerly NAFLD). The combination of elevated ferritin with normal TSAT and elevated GGT strongly suggests metabolic hyperferritinemia rather than hemochromatosis [14].

For confirmed iron overload (TSAT >45% on two separate fasting draws), HFE genotyping is the next step. The C282Y homozygous mutation accounts for approximately 85 to 90% of hereditary hemochromatosis in Northern European populations [4]. If HFE is negative, an MRI-based liver iron concentration (LIC) measurement can quantify hepatic iron directly. T2*-weighted MRI is the current non-invasive reference standard, with an LIC above 3.2 mg/g dry weight considered clinically significant [15].

Vitamin B12, Folate, and Thyroid Panel: The Extended Workup

Iron deficiency rarely exists in nutritional isolation. A patient with low ferritin due to poor dietary intake or malabsorption may also be deficient in vitamin B12 and folate, both of which affect red cell production and can mask or alter the classic microcytic picture of iron deficiency. Combined iron and B12 deficiency produces a "dimorphic" blood film with both microcytic and macrocytic cells, often resulting in a normal MCV that hides both deficiencies.

Thyroid function (TSH at minimum, with free T4 if abnormal) is worth ordering alongside ferritin in two clinical contexts. First, hypothyroidism independently reduces iron absorption and is associated with a 2- to 3-fold increased risk of iron deficiency [16]. Second, ferritin is increasingly ordered in the workup of hair loss, where iron deficiency and thyroid dysfunction are the two most common reversible causes. The British Association of Dermatologists recommends ferritin, TSH, and CBC as the minimum panel for non-scarring alopecia [17].

How to Raise Ferritin When It Is Low

Oral iron supplementation remains first-line for most patients with iron-deficiency without severe anemia. Ferrous sulfate 325 mg (65 mg elemental iron) taken every other day on an empty stomach produces absorption equivalent to daily dosing but with fewer GI side effects, according to a 2015 randomized crossover trial (N=54) by Stoffel et al. published in The Lancet Haematology [18]. Hepcidin levels rise for 24 hours after an iron dose, so alternate-day dosing allows hepcidin to clear before the next dose.

Vitamin C (200 mg) taken with the iron tablet increases non-heme iron absorption by reducing ferric to ferrous iron in the duodenum. Avoid taking iron within 2 hours of calcium supplements, proton pump inhibitors, or tea/coffee, all of which reduce absorption.

IV iron (ferric carboxymaltose, iron sucrose, or ferumoxytol) is indicated when oral iron is not tolerated, absorption is impaired (celiac disease, post-bariatric surgery, inflammatory bowel disease), or rapid repletion is needed (hemoglobin <8 g/dL, symptomatic heart failure, upcoming surgery) [19].

How to Lower Ferritin When It Is Elevated

The approach depends entirely on the cause. If TSAT confirms iron overload and HFE testing reveals hemochromatosis, therapeutic phlebotomy is the mainstay, typically removing 500 mL of whole blood (approximately 250 mg of iron) weekly until ferritin drops below 50 ng/mL, then transitioning to maintenance phlebotomy every 2 to 4 months [4].

If elevated ferritin reflects metabolic syndrome or MASLD rather than true iron excess, the treatment targets the metabolic drivers. Weight loss of 5 to 10% of body weight reduces ferritin by 30 to 50% in patients with MASLD, as demonstrated in a 2019 trial published in Gastroenterology (N=261) [20]. Exercise, alcohol reduction, and management of insulin resistance are the primary interventions. Phlebotomy is not routinely recommended for metabolic hyperferritinemia, though some evidence suggests it may improve insulin sensitivity. A 2012 RCT in JAMA Internal Medicine (N=74) showed that phlebotomy to near-iron deficiency reduced HbA1c by 0.5% in patients with metabolic syndrome and elevated ferritin [21].

If inflammation is the driver, treating the underlying condition (autoimmune disease, chronic infection) is the correct approach. Lowering ferritin artificially through phlebotomy in these patients could worsen anemia of chronic disease.

Timing and Preparation for the Paired Panel

Draw the full panel fasting, ideally in the morning. Serum iron has a diurnal variation of up to 30%, with peak levels in the late morning and a nadir in the evening. A 2017 study in Clinical Chemistry (N=2,466) confirmed that non-fasting TSAT values led to misclassification of iron overload status in 12% of patients [22]. Fasting for 8 to 12 hours eliminates postprandial iron spikes that inflate serum iron and TSAT while leaving ferritin, CBC, and CRP unaffected.

Avoid drawing the panel during acute illness. Wait at least 2 weeks after resolution of a febrile illness or acute inflammatory event. If the clinical situation demands testing during illness (for example, inpatient evaluation for severe anemia), order sTfR alongside ferritin and CRP to improve diagnostic accuracy despite the inflammatory confounding.

Iron supplements should be held for 24 to 48 hours before the draw to avoid artificially elevated serum iron levels. Note that ferritin itself is not affected by a single dose of iron, since it reflects chronic stores rather than acute intake.